Eric A Dietrich

Eric A Dietrich, Pharm.D., BCACP, CPC-A, CEMC, CPB

Clinical Associate Professor

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 294-5648
Business Email: dietrich@cop.ufl.edu

About Eric A Dietrich

Dr. Dietrich is a Clinical Associate Professor within the Department of Pharmacotherapy and Translational Research. His work involves managing an Anticoagulation Clinic at UF Health Internal Medicine at Tower Hill monitoring warfarin as well as DOACs in addition to a multidisciplinary transitions of care clinic for patients with a recent acute myocardial infarction. Dr. Dietrich’s research interests include interventions aimed at reducing anticoagulation, hypertension, cardiovascular disease, and pharmacy billing and reimbursement for clinical services in collaborative clinical environments. Dr. Dietrich is a Board Certified Ambulatory Care Pharmacist as well as a Certified Professional Coder. Dr. Dietrich’s teaching focuses on anticoagulation and cardiovascular disease and he is the Program Director for the UF College of Pharmacy PGY2 Specialty Residency in Ambulatory Care. Dr. Dietrich’s wife, Nicole, is a pharmacist at the VA.

Accomplishments

Member
2016-current · American Academy of Profession Coders
Member
2011-current · American College of Clinical Pharmacy

Research Profile

Areas of Interest
  • Anticoagulation; DOAC monitoring
  • Collaborative Practice Models
  • Hypertension
  • Pharmacy Billing and Reimbursement

Publications

2020
Ambulatory care elective: Introduction to core practice concepts.
Currents in pharmacy teaching & learning. 12(3):331-338 [DOI] 10.1016/j.cptl.2019.12.013. [PMID] 32273072.
2020
Comparative effectiveness and safety of apixaban versus warfarin in patients with venous thromboembolism.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 77(3):188-195 [DOI] 10.1093/ajhp/zxz307. [PMID] 31974557.
2020
Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
Clinical therapeutics. 42(9):e161-e176 [DOI] 10.1016/j.clinthera.2020.06.022. [PMID] 32768247.
2020
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic.
Journal of clinical medicine. 9(7) [DOI] 10.3390/jcm9072274. [PMID] 32708920.
2020
Out-of-Pocket Payment for Ambulatory Blood Pressure Monitoring Among Commercially Insured in the United States.
American journal of hypertension. 33(11):999-1002 [DOI] 10.1093/ajh/hpaa120. [PMID] 32930343.
2020
Trends in ambulatory blood pressure monitoring use for confirmation or monitoring of hypertension and resistant hypertension among the commercially insured in the U.S., 2008-2017.
International Journal of Cardiology. Hypertension. 6 [DOI] 10.1016/j.ijchy.2020.100033. [PMID] 33447762.
2019
A stepwise approach to implementing pharmacogenetic testing in the primary care setting.
Pharmacogenomics. 20(15):1103-1112 [DOI] 10.2217/pgs-2019-0053. [PMID] 31588877.
2019
Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation.
Therapeutic advances in drug safety. 10 [DOI] 10.1177/2042098619888133. [PMID] 31807265.
2019
Antibiotic Stewardship for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
American journal of therapeutics. 26(4):e499-e501 [DOI] 10.1097/MJT.0000000000000717. [PMID] 29561269.
2019
Can apixaban prevent venous thromboembolism better than rivaroxaban? – Authors’ reply.
The Lancet. Haematology. 6(4):e181-e182 [DOI] 10.1016/S2352-3026(19)30049-3. [PMID] 30926080.
2019
Comparative Effectiveness and Safety of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome: A Retrospective Cohort Analysis.
Pharmacotherapy. 39(9):912-920 [DOI] 10.1002/phar.2311. [PMID] 31332815.
2019
Comparison of Factors Identified by Patients and Physicians Associated with Hospital Readmission (COMPARE2).
Southern medical journal. 112(4):244-250 [DOI] 10.14423/SMJ.0000000000000959. [PMID] 30943545.
2019
Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis.
The Lancet. Haematology. 6(1):e20-e28 [DOI] 10.1016/S2352-3026(18)30191-1. [PMID] 30558988.
2019
Effects of Oral Ginger Supplementation on the INR.
Case reports in medicine. 2019 [DOI] 10.1155/2019/8784029. [PMID] 31281366.
2019
Patient-level adherence and interventions in an interdisciplinary DOAC clinic.
Thrombosis research. 179:34-36 [DOI] 10.1016/j.thromres.2019.04.021. [PMID] 31075700.
2019
Risk of Daptomycin-associated Myopathy With Concomitant Statin Use.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 69(3):558-559 [DOI] 10.1093/cid/ciy1097. [PMID] 30596967.
2018
Antibiotic use in patients hospitalized with chronic obstructive pulmonary disease.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 75(17):1268-1269 [DOI] 10.2146/ajhp180178. [PMID] 30139734.
2018
Evaluation of SAMe-TT2R2 Score on Predicting Success With Extended-Interval Warfarin Monitoring.
The Annals of pharmacotherapy. 52(11):1085-1090 [DOI] 10.1177/1060028018779774. [PMID] 29857777.
2018
Incident-to Billing for Pharmacists.
Journal of managed care & specialty pharmacy. 24(12):1273-1276 [DOI] 10.18553/jmcp.2018.24.12.1273. [PMID] 30479200.
2017
Resistant Hypertension: Mechanisms and Treatment.
Current hypertension reports. 19(7) [DOI] 10.1007/s11906-017-0754-x. [PMID] 28597403.
2016
Addressing Hospital Readmissions: Impact of Weekly Review.
Family medicine. 48(8):638-41 [PMID] 27655198.
View on: PubMed
2016
Patient satisfaction with extended-interval warfarin monitoring.
Journal of thrombosis and thrombolysis. 42(4):486-93 [DOI] 10.1007/s11239-016-1385-9. [PMID] 27251646.
2016
Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.
Journal of the American Society of Hypertension : JASH. 10(4):307-17 [DOI] 10.1016/j.jash.2016.01.010. [PMID] 26852290.
2015
Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Postgraduate medicine. 127(7):702-15 [DOI] 10.1080/00325481.2015.1050340. [PMID] 26012731.
2015
Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 72(19):1623-9 [DOI] 10.2146/ajhp140804. [PMID] 26386103.
2015
Feasibility of Extended-interval Follow-up for Patients Receiving Warfarin.
Cardiovascular therapeutics. 33(3):98-103 [DOI] 10.1111/1755-5922.12115. [PMID] 25786578.
2014
A Statin a Day to Keep the Doctor Away? Comparing Aspirin and Statins for Primary Prevention of Cardiovascular Disease.
The Annals of pharmacotherapy. 48(9):1238-1241 [PMID] 24958491.
View on: PubMed
2014
Davis and Dietrich’s response to Abramson and colleagues’ article on statins in low risk people.
BMJ (Clinical research ed.). 348 [DOI] 10.1136/bmj.g1795. [PMID] 24574491.
2014
Feasibility of Extended Duration Follow-Up for Patients Receiving Warfarin.
Pharmacotherapy. 34(10)
2013
Canagliflozin: a novel treatment option for type 2 diabetes.
Drug design, development and therapy. 7:1399-408 [DOI] 10.2147/DDDT.S48937. [PMID] 24285921.
2013
Lorcaserin for weight management.
Diabetes, metabolic syndrome and obesity : targets and therapy. 6:209-16 [DOI] 10.2147/DMSO.S36276. [PMID] 23788837.
2013
New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity.
Clinical therapeutics. 35(1):A3-17 [DOI] 10.1016/j.clinthera.2012.12.012. [PMID] 23328274.
2013
Tracking Thrombosis and Pain Metrics in a Status- Post Orthopedic Surgical Population: Results From a Participating Institution in the Surgical Outcomes Project.
Pharmacotherapy. 33:E227-E228
2012
Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.
The Annals of pharmacotherapy. 46(10):1382-91 [DOI] 10.1345/aph.1R069. [PMID] 23012382.
2012
Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.
The Annals of pharmacotherapy. 46(10):1382-91 [DOI] 10.1345/aph.1R069. [PMID] 23012382.

Grants

Oct 2019 ACTIVE
Quality of care for inferior vena cava filters at UF Health Shands Hospital
Role: Co-Investigator
Funding: UF HEALTH SHANDS HOSPITAL
Mar 2017 – Mar 2019
Pharmacogenetic Consultation Service
Role: Principal Investigator
Funding: UF HEALTH SHANDS HOSPITAL

Education

Certified Evaluation and Management Coder (CEMC)
2018 · American Academy of Professional Coders
Certified Profession Coder (CDC),
2016 · American Academy of Professional Coders
Post-doctoral fellow, Family Medicine
2011-2013 · University of Florida
Pharm. D.
2011 · University of Florida

Teaching Profile

Courses Taught
2018,2020-2021
PHA5878C Pt Care 3: Cv and Pulm
2018-2021
PHA5876C Pt Care 8 Complex Pts
2018-2019,2021
PHA5789C Patient Care 7
2018
PHA5788C Patient Care 6
2018
PHA5763 Ambulatory Care Advanced Pharmacy Practice Experience
2018,2020-2021
PHA5060 Ambulatory Care
2012-2018
PHA5788 Pharmacotherapy 6
2016-2017
PHA5787 Pharmacotherapy 5
2014-2016
PHA5784 Pharmacotherapy 4
2015-2016
PHA5933 Select Top Pharmacy
2015
PHA6634 Medication Therapy Management: An Endocrine Focus
2015
PHA5907 Research in Phar Prac
2012-2015
PHA5783 Pharmacotherapy 3
2011
PHA5782 Pharmacotherapy 2

Contact Details

Phones:
Business:
(352) 294-5648
Emails: